Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.10 USD
27.59 M USD
285.50 M USD
296.01 M
About MannKind Corporation
Sector
Industry
CEO
Michael E. Castagna
Website
Headquarters
Danbury
Founded
1991
FIGI
BBG000PPL3G9
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
MNKD - risky catalyst playMannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inh
Small Cap Bio: MNKD - Multi-Year ConsolidationPotential multi-bagger setting up as it's coiling on the monthly/quarterly. Confirmation on a monthly close over 6.30. Ideally holds for a quarterly confirmation (End of September > 6.30)
Weekly:
Still possible it does one more fake move into the 4s before making a big move higher.
Daily:
Watchlist 2023-02-22 #OSTK #MNKD #HD #TGNA #PANWSPY - did not make a higher high the entire day as sellers were firmly in control. Opening in the PM at the key 400 level. With the VIX finally spiking yesterday and bond prices making new lows., it appears like the price action and market internals indicate this short term bear action will continue
Can MNKD be heading for a run up to $8.40'sMNKD has been consolidating for want seems to be forever, but since April of 2020 it's been catching a little bit of a pump which peaked sometime in March of this year. Since then it has created a symmetrical triangle. On its own a symmetrical triangle does not mean much, but if we look at other ind
MNKD Fibbin AgainMNKD is back at a frequent level of "traffic" this week. After doing a quick retracement we can see that the 618 area continues to act as a magnate a key pivot area. After bouncing off this last time, MNKD has continued higher on a decent multi-day move. Now, moving forward, a fundamental focus cou
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of MNKD is 4.54 USD — it has increased by 0.22% in the past 24 hours. Watch MannKind Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange MannKind Corporation stocks are traded under the ticker MNKD.
MNKD stock has fallen by −3.61% compared to the previous week, the month change is a −13.03% fall, over the last year MannKind Corporation has showed a 11.00% increase.
We've gathered analysts' opinions on MannKind Corporation future price: according to them, MNKD price has a max estimate of 12.00 USD and a min estimate of 9.00 USD. Watch MNKD chart and read a more detailed MannKind Corporation stock forecast: see what analysts think of MannKind Corporation and suggest that you do with its stocks.
MNKD reached its all-time high on Sep 24, 2004 with the price of 121.55 USD, and its all-time low was 0.67 USD and was reached on May 3, 2017. View more price dynamics on MNKD chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
MNKD stock is 2.24% volatile and has beta coefficient of 0.64. Track MannKind Corporation stock price on the chart and check out the list of the most volatile stocks — is MannKind Corporation there?
Today MannKind Corporation has the market capitalization of 1.38 B, it has decreased by −1.07% over the last week.
Yes, you can track MannKind Corporation financials in yearly and quarterly reports right on TradingView.
MannKind Corporation is going to release the next earnings report on May 7, 2025. Keep track of upcoming events with our Earnings Calendar.
MNKD earnings for the last quarter are 0.03 USD per share, whereas the estimation was 0.036 USD resulting in a −16.00% surprise. The estimated earnings for the next quarter are 0.043 USD per share. See more details about MannKind Corporation earnings.
MannKind Corporation revenue for the last quarter amounts to 76.78 M USD, despite the estimated figure of 74.37 M USD. In the next quarter, revenue is expected to reach 76.02 M USD.
MNKD net income for the last quarter is 7.42 M USD, while the quarter before that showed 11.55 M USD of net income which accounts for −35.74% change. Track more MannKind Corporation financial stats to get the full picture.
No, MNKD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 20, 2025, the company has 407 employees. See our rating of the largest employees — is MannKind Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MannKind Corporation EBITDA is 77.65 M USD, and current EBITDA margin is 27.20%. See more stats in MannKind Corporation financial statements.
Like other stocks, MNKD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MannKind Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MannKind Corporation technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MannKind Corporation stock shows the sell signal. See more of MannKind Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.